Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while ...

Looking ahead to fiscal year 2026, Evercore ISI projects an EPS growth of roughly 7% to $9.10. This forecast is based on a ...

Evercore ISI lowered the firm’s price target on Moderna (MRNA) to $50 from $60 and keeps an In Line rating on the shares. The firm is updating ...

Evercore ISI raised the firm’s price target on Verizon (VZ) to $44 from $42 and keeps an In Line rating on the shares. Verizon exited 2024 with ...

Discover the top U.S. Quant-rated industrial stocks with strong potential for growth and profitability in the current market ...

We recently published a list of Top 10 AI News You Shouldn’t Miss. In this article, we are going to take a look at where ...

Evercore ISI added United Parcel Service ( NYSE: UPS) to its Tactical Outperform list ahead of the parcel delivery giant's ...

The Nasdaq 100 Index has nearly doubled since the start of 2023, adding $14 trillion in value in the process. Evercore ISI’s ...

Evercore ISI Director of Research Marc Harris said, “Artificial intelligence is already a transformative force in the U.S. economy, revolutionizing industries and driving innovation. Scaling ...

6) Credit Market Turmoil: Another possible surprise that could occur in 2025 is a widening of credit spreads, even without a recession. Growth concerns stemming from China or US policy uncertainty ...

Evercore ISI raised the firm’s price target on Arista Networks (ANET) to $130 from $110 and keeps an Outperform rating on the ...

Evercore ISI analyst Amit Daryanani lowered the firm’s price target on Sensata (ST) to $40 from $43 and keeps an Outperform rating on the shares. The firm remains constructive on companies tied to ...